Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia

Area of Science:

• Neuroscience
• Cerebrovascular Medicine
• Pathology

Background:

• Vascular dementia (VaD) is the second leading cause of dementia, following Alzheimer's disease (AD).
• Cerebrovascular disease triggers VaD by damaging cerebrovascular endothelial cells (CECs), leading to cognitive decline.
• CEC dysfunction precedes VaD onset, causing cerebral blood flow dysregulation and blood-brain barrier compromise.

Purpose of the Study:

• To review the mechanisms of CEC impairment in hypoperfusion relevant to VaD.
• To elucidate the pathological role of CECs in the development of VaD.
• To identify potential therapeutic targets for VaD treatment based on CEC dysfunction.

Main Methods:

• Literature review focusing on cerebrovascular endothelial cell function in hypoperfusion models.
• Analysis of signaling pathways implicated in CEC dysfunction and VaD.
• Synthesis of current research on the role of CECs in cognitive impairment.

Main Results:

• CEC dysfunction is a critical early event in VaD pathogenesis.
• Impaired CECs contribute to neuroinflammation and neuronal damage.
• Key pathways involved include endothelial nitric oxide synthase (eNOS)/nitric oxide (NO), Ras homolog gene family member A (RhoA), and caveolin-1 (CAV-1).

Conclusions:

• Targeting the eNOS/NO and RhoA signaling pathways presents a promising therapeutic strategy for VaD.
• CEC-derived caveolin-1 (CAV-1) is identified as a potential drug target for VaD.
• Further research into CEC-mediated mechanisms could lead to novel treatments for vascular dementia.